Prestara Changes Course: Development To Focus on Lupus Signs And Symptoms

Genelabs will no longer pursue a Prestara indication for prevention of loss of bone mineral density in women with lupus.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet